Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment.
about
From bench to bedside a comprehensive review of pancreatic cancer immunotherapy.Effects of radiation on T regulatory cells in normal states and cancer: mechanisms and clinical implicationsRemodeling Components of the Tumor Microenvironment to Enhance Cancer TherapyRadiation meets immunotherapy - a perfect match in the era of combination therapy?The Evolving Role of Immune Checkpoint Inhibitors in Cancer TreatmentImmunological battlefield in gastric cancer and role of immunotherapiesTrial Watch: Peptide-based anticancer vaccines.The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapy.An ecological measure of immune-cancer colocalization as a prognostic factor for breast cancer.Quantitative histology analysis of the ovarian tumour microenvironment.Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancerImmune biomarkers: how well do they serve prognosis in human cancers?The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis.Peptide vaccines for the treatment of glioblastoma.Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections.Extending the lifespan and efficacies of immune cells used in adoptive transfer for cancer immunotherapies-A review.Immune Therapy.Differential expression of major histocompatibility complex class I in subtypes of breast cancer is associated with estrogen receptor and interferon signalingIncreasing radiation dose improves immunotherapy outcome and prolongation of tumor dormancy in a subgroup of mice treated for advanced intracerebral melanoma.Indoleamine 2,3-dioxygenase and survivin peptide vaccine combined with temozolomide in metastatic melanoma.CAR-T cells and combination therapies: What's next in the immunotherapy revolution?Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer.A bifunctional nanomodulator for boosting CpG-mediated cancer immunotherapy.Cytokine evaluation in untreated and radioimmunotherapy-treated tumors in an immunocompetent rat model.Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models.
P2860
Q26765123-474F5166-03DD-47C2-8E48-8827911E0FCDQ26774934-964431B8-4E3D-4D67-951F-FC90CA01FDBBQ26777144-66DA905F-B63F-4742-9005-4AB83A086FB3Q27005913-79F5C479-53E0-48E7-8A52-E07728DD8360Q27022789-E9A2CF06-9CD6-4EA4-BE9D-267DDE19885DQ28071836-807592DF-24C2-4C5B-AB77-870F262EA8D4Q34483345-09815131-5E34-4FC9-B467-A00E5C8AB4C9Q35547103-CD7BBB18-70B3-4395-8148-F2D11E8CA56DQ36085118-6439C27B-7AC7-4BAA-88AB-646B13A6BD9DQ36285900-F6091635-F72E-4EF0-986E-8CD9678FF86AQ37609431-7362BC04-74E8-4B8A-AAE2-E66358DA104CQ38262757-035CAFE2-5503-43D5-B690-B03FC5DCFB9FQ38264173-8657B2FB-6C43-4225-9818-760D75B5B0AEQ38285889-E960663A-CBEE-4A60-96E8-93487050518BQ38417056-6C12BCAF-0EAB-4356-817A-3138AE9A13D0Q38544057-0AD45D01-82C4-4960-8600-F6F42DB26ADEQ38669273-FEDA7738-57D9-4A32-A315-D6007123DB84Q38775011-35822410-9611-446A-B10F-00D99154BE35Q38812183-8467BD32-83C4-4F56-A957-C8EBCA9CE207Q45738938-7B9D0D65-0111-4BCB-82C4-94000AC81E05Q47285613-C94A6500-EE18-4827-B5D7-B9A001FFFD00Q50042810-7F3D669C-8723-4DB9-A29C-97F4D9869725Q50072990-D75AFE4B-4D6F-4644-9EAC-A0E257F55F1AQ51070198-C5F6D7FF-1B6C-42D2-9C81-A92C7D74F0ADQ52598486-5A8768C4-A7FB-4FFC-990C-BCDF1484D764
P2860
Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Enhancing immunotherapy using ...... fy the tumor microenvironment.
@en
Enhancing immunotherapy using ...... fy the tumor microenvironment.
@nl
type
label
Enhancing immunotherapy using ...... fy the tumor microenvironment.
@en
Enhancing immunotherapy using ...... fy the tumor microenvironment.
@nl
prefLabel
Enhancing immunotherapy using ...... fy the tumor microenvironment.
@en
Enhancing immunotherapy using ...... fy the tumor microenvironment.
@nl
P2093
P2860
P356
P1433
P1476
Enhancing immunotherapy using ...... fy the tumor microenvironment.
@en
P2093
Christel Devaud
Jennifer A Westwood
Liza B John
P2860
P304
P356
10.4161/ONCI.25962
P577
2013-08-02T00:00:00Z